# CrisprQC

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/crisprqc

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.crisprqc.com
- Total disclosed funding: $12M
- Latest round: Series A (Jan 4, 2024)
- Investors on record: 3

## About

Based in California, US, and founded in 2021, CrisprQC Inc. develops an analytics platform built on CRISPR-Chip. The company was co-founded by Ross Bundy (CEO) and DR. Kiana Aran. In January 2023, CrisprQC Inc. raised USD 1.6 million in Seed funding led by investor Serra Ventures, with participation from another investor CaerusX Ventures.

The company offers an analytics platform that is built on CRISPR-Chip that provides data and analytics for CRISPR gene editing. Additionally, the applications include gene cell and gene therapies, diagnostics, plant and animal biology, and academic research.

The company plans to use January 2023 the funding to advance the commercial development of the CRISPR Analytics Platform and enhance data analytics capabilities.

## Funding rounds

- Series A, Jan 4, 2024, $10M — Xcellerant Ventures
- Seed, Jan 9, 2023, $1.6M — Serra Ventures, CaerusX Ventures

## Investors

- Serra Ventures (https://capitalatlas.ai/funds/serra-ventures) — Seed
- CaerusX Ventures — Seed
- Xcellerant Ventures (https://capitalatlas.ai/funds/xcellerant-ventures) — Series A